Evidence map›Paper›PMID 15800195›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2005

Relationship between membrane phosphatidylinositol-4,5-bisphosphate and receptor-mediated inhibition of native neuronal M channels.

Joanna S Winks, Simon Hughes, Alexander K Filippov, Lucine Tatulian, Fe C Abogadie, David A Brown, Stephen J Marsh

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 170 citations in OpenAlex.

  1. Topical review: Potential mechanisms of atropine for myopia control.Optometry and vision science : official publication of the American Academy of Optometry · 2025
    Review
  2. Article
  3. Calcium-sensing receptor regulates Kv7 channels via GBritish journal of pharmacology · 2024
    Article
  4. Article
  5. Article
  6. Involvement of CaCellular and molecular neurobiology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Chemical modulation of Kv7 potassium channels.RSC medicinal chemistry · 2021
    Review
  15. Article
  16. Article
  17. Pharmacological Manipulation of KFrontiers in physiology · 2020
    Review
  18. Review
  19. Article
  20. Phosphatidylinositol 4,5-bisphosphate (PIPThe Journal of biological chemistry · 2018
    Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joanna S Winks1Ion Channel Pharmacology Group, IPC 388, Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent CT13 9NJ, United Kingdom.
Simon Hughes
Alexander K Filippov
Lucine Tatulian
Fe C Abogadie
David A Brown
Stephen J Marsh
University College London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The relationship between receptor-induced membrane phosphatidylinositol-4'5'-bisphosphate (PIP2) hydrolysis and M-current inhibition was assessed in single-dissociated rat sympathetic neurons by simultaneous or parallel recording of membrane current and membrane-to-cytosol translocation of the fluorescent PIP2/inositol 1,4,5-trisphosphate (IP3)-binding peptide green fluorescent protein-tagged pleckstrin homology domain of phospholipase C (GFP-PLCdelta-PH). The muscarinic receptor agonist oxotremorine-M produced parallel time- and concentration-dependent M-current inhibition and GFP-PLCdelta-PH translocation; bradykinin also produced parallel time-dependent inhibition and translocation. Phosphatidylinositol-4-phosphate-5-kinase (PI5-K) overexpression reduced both M-current inhibition and GFP-PLCdelta-PH translocation by both oxotremorine-M and bradykinin. These effects were partly reversed by wortmannin, which inhibits phosphatidylinositol-4-kinase (PI4-K). PI5-K overexpression also reduced the inhibitory action of oxotremorine-M on PIP2-gated G-protein-gated inward rectifier (Kir3.1/3.2) channels; bradykinin did not inhibit these channels. Overexpression of neuronal calcium sensor-1 protein (NCS-1), which increases PI4-K activity, did not affect responses to oxotremorine-M but reduced both fluorescence translocation and M-current inhibition by bradykinin. Using an intracellular IP3 membrane fluorescence-displacement assay, initial mean concentrations of membrane [PIP2] were estimated at 261 microm (95% confidence limit; 192-381 microm), rising to 693 microm (417-1153 microm) in neurons overexpressing PI5-K. Changes in membrane [PIP2] during application of oxotremorine-M were calculated from fluorescence data. The results, taken in conjunction with previous data for KCNQ2/3 (Kv7.2/Kv7.3) channel gating by PIP2 (Zhang et al., 2003), accorded with the hypothesis that the inhibitory action of oxotremorine-M on M current resulted from depletion of PIP2. The effects of bradykinin require additional components of action, which might involve IP3-induced Ca2+ release and consequent M-channel inhibition (as proposed previously) and stimulation of PIP2 synthesis by Ca2+-dependent activation of NCS-1.

Indexed as

AnimalsAnimals, NewbornBradykininCalciumCalcium-Binding ProteinsCell MembraneCells, CulturedDose-Response Relationship, DrugDrug InteractionsElectric StimulationEstrenesFemaleFluorescent DyesGene ExpressionG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGreen Fluorescent Proteins1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dioneBradykininCalciumCalcium-Binding ProteinsEstrenesFluorescent Dyesfrequenin calcium sensor proteinsG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGreen Fluorescent ProteinsIsoenzymesMuscarinic AgonistsNeuronal Calcium-Sensor ProteinsNeuropeptidesOxotremorineoxotremorine MPhosphatidylinositol 4,5-DiphosphatePhosphodiesterase InhibitorsPhospholipase C deltaPyrrolidinonesReceptors, MuscarinicType C Phospholipases

Identifiers

PMID15800195
PMCPMC6724893
OpenAlexW2070189344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.